Page last updated: 2024-08-17

bromodeoxyuridine and Mast Cell Activation Disease

bromodeoxyuridine has been researched along with Mast Cell Activation Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Daxnerová, Z; Hrckova, G; Solár, P; Velebný, S	1

Other Studies

1 other study(ies) available for bromodeoxyuridine and Mast Cell Activation Disease

Article	Year
Praziquantel and liposomized glucan-treatment modulated liver fibrogenesis and mastocytosis in mice infected with Mesocestoides vogae (M. corti, Cestoda) tetrathyridia. Parasitology, 2006, Volume: 132, Issue:Pt 4 Topics: Animals; Anthelmintics; beta-Glucans; Bromodeoxyuridine; Cestode Infections; Collagen; Drug Therapy, Combination; Hydroxyproline; Immunohistochemistry; Liposomes; Liver; Liver Cirrhosis; Male; Mast Cells; Mastocytosis; Mesocestoides; Mice; Mice, Inbred ICR; Praziquantel; Thymidine; Tolonium Chloride; Tritium	2006

Article

Year

Praziquantel and liposomized glucan-treatment modulated liver fibrogenesis and mastocytosis in mice infected with Mesocestoides vogae (M. corti, Cestoda) tetrathyridia.

Parasitology, 2006, Volume: 132, Issue:Pt 4

Topics: Animals; Anthelmintics; beta-Glucans; Bromodeoxyuridine; Cestode Infections; Collagen; Drug Therapy, Combination; Hydroxyproline; Immunohistochemistry; Liposomes; Liver; Liver Cirrhosis; Male; Mast Cells; Mastocytosis; Mesocestoides; Mice; Mice, Inbred ICR; Praziquantel; Thymidine; Tolonium Chloride; Tritium

2006